Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Silber

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
Frontiers in Chemistry|November 16, 2020
Targeting L-Proline Uptake as New Strategy for Anti-chagas Drug DevelopmentLucía Fargnoli, Esteban A Panozzo-Zénere, Lucas Pagura, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Pharmacokinetics of nilvadipine after single oral doses in healthy volunteersW K Cheung, D L Woodward, K Shin, et al.
International Journal of Nanomedicine|October 17, 2012
Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infectionsV Grazú, A M Silber, M Moros, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Pep5, a Fragment of Cyclin D2, Shows Antiparasitic Effects in Different Stages of the <i>Trypanosoma cruzi</i> Life Cycle and Blocks Parasite InfectivityChristiane Bezerra de Araujo, Loyze Paola de Lima, Simone Guedes Calderano, et al.
Journal of Clinical Pharmacology|November 1, 1988
Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipineW K Cheung, L L Sia, D L Woodward, et al.
AAPS Pharmsci|December 14, 2001
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial settingS McElroy, C Sachse, J Brockmoller, et al.
Journal of Clinical Pharmacology|October 1, 1987
Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady stateR D Faulkner, W Bohaychuk, R E Desjardins, et al.
FEBS Letters|November 5, 2003
Arginine kinase overexpression improves Trypanosoma cruzi survival capabilityClaudio A Pereira, Guillermo D Alonso, Soledad Ivaldi, et al.
Journal of Pediatric Hematology/Oncology|November 23, 2006
Teaching teachers about childhood cancer: the effects of a web-based training programRonald L Dubowy, Brian P Rieger, Nan S Songer, et al.
Journal of Clinical Pharmacology|August 1, 1988
Absolute bioavailability of cefixime in manR D Faulkner, P Fernandez, G Lawrence, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
Frontiers in Chemistry|November 16, 2020
Targeting L-Proline Uptake as New Strategy for Anti-chagas Drug DevelopmentLucía Fargnoli, Esteban A Panozzo-Zénere, Lucas Pagura, et al.
International Journal of Clinical Pharmacology Research|January 1, 1988
Pharmacokinetics of nilvadipine after single oral doses in healthy volunteersW K Cheung, D L Woodward, K Shin, et al.
International Journal of Nanomedicine|October 17, 2012
Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infectionsV Grazú, A M Silber, M Moros, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2019
Pep5, a Fragment of Cyclin D2, Shows Antiparasitic Effects in Different Stages of the <i>Trypanosoma cruzi</i> Life Cycle and Blocks Parasite InfectivityChristiane Bezerra de Araujo, Loyze Paola de Lima, Simone Guedes Calderano, et al.
Journal of Clinical Pharmacology|November 1, 1988
Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipineW K Cheung, L L Sia, D L Woodward, et al.
AAPS Pharmsci|December 14, 2001
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial settingS McElroy, C Sachse, J Brockmoller, et al.
Journal of Clinical Pharmacology|October 1, 1987
Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady stateR D Faulkner, W Bohaychuk, R E Desjardins, et al.
FEBS Letters|November 5, 2003
Arginine kinase overexpression improves Trypanosoma cruzi survival capabilityClaudio A Pereira, Guillermo D Alonso, Soledad Ivaldi, et al.
Journal of Pediatric Hematology/Oncology|November 23, 2006
Teaching teachers about childhood cancer: the effects of a web-based training programRonald L Dubowy, Brian P Rieger, Nan S Songer, et al.
Journal of Clinical Pharmacology|August 1, 1988
Absolute bioavailability of cefixime in manR D Faulkner, P Fernandez, G Lawrence, et al.
Pageof 16